实验室确诊的无症状SARS-CoV-2(COVID-19)感染在18F-FDG PET/CT上的表现
一名87岁原发性唾液腺导管癌伴肝转移男性患者因再分期行18F-FDG PET/CT,显示双肺新发FDG摄取增高的磨玻璃影伴小叶间隔增厚、外周分布为主,影像高度提示COVID-19肺炎;患者当时无症状且无活动性肺炎临床证据,但实时逆转录聚合酶链反应检测COVID-19阳性。
要点
- 无症状门诊患者在疫情期间行PET/CT时也应评估提示COVID-19的影像学表现。
- 双肺新发FDG高摄取磨玻璃影伴小叶间隔增厚、外周分布为主高度提示COVID-19肺炎。
- 影像高度提示COVID-19时应联系转诊医生,即使患者无症状。
核心结论
- 本病例表明,疫情期间即使是无症状的门诊PET/CT患者,也应评估提示COVID-19的影像学表现。
研究设计与样本
- 病例报告:一名87岁原发性唾液腺导管癌伴肝转移男性患者因再分期行18F-FDG PET/CT。
主要发现
- 18F-FDG PET/CT显示双肺新发FDG摄取增高的磨玻璃影伴小叶间隔增厚,外周分布为主,判读为高度提示COVID-19肺炎的模式并联系了转诊医生。
- 患者当时无症状且无活动性肺炎的临床证据,但实时逆转录聚合酶链反应检测COVID-19阳性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
An 87-year-old man with primary salivary duct carcinoma and hepatic metastases was referred for restaging. F-FDG PET/CT demonstrated new FDG-avid ground-glass opacities with intralobular septal thickening in both lungs with a peripheral dominant distribution. This was interpreted as a pattern highly suggestive of COVID-19 pneumonia, and the referring physician was contacted. The patient was currently asymptomatic and without clinical evidence of active pneumonia. However, the patient tested positive for COVID-19 using real-time reverse transcription-polymerase chain reaction. This case demonstrates that even asymptomatic outpatients undergoing PET/CT should be evaluated for radiologic findings suggestive of COVID-19 during this pandemic.
引用
- Krebs S, Petkovska I, Ho AL, et al. Laboratory-Proven Asymptomatic SARS-CoV-2 (COVID-19) Infection on 18F-FDG PET/CT. Clin Nucl Med. 2020. PMID: 32433161. doi:10.1097/RLU.0000000000003141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。